Orange Book product · Brand (NDA)

VIVLODEX

MELOXICAM

Brand (NDA)NDA 207233DISCN ICEUTICA OPERATIONS

Oct 22, 2015

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
Oct 22, 2015
10 yr 10 mo ago
Today
Patent 9526734 expires
Listed drug product patent expiration.
Mar 31, 2033
in 6 yr 11 mo
Patent 9649318 expires
Listed drug product patent expiration.
Mar 31, 2035
in 8 yr 11 mo
Patent 9808468 expires
Listed method-of-use patent (U-2165) expiration.
Mar 31, 2035
in 8 yr 11 mo
Patent 9808468 expires
Listed method-of-use patent (U-2160) expiration.
Mar 31, 2035
in 8 yr 11 mo

Active ingredient

MELOXICAM

Strength

5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

NDA 207233

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
9526734	Mar 31, 2033	in 6 yr 11 mo	Product
9649318	Mar 31, 2035	in 8 yr 11 mo	Product
9808468	Mar 31, 2035	in 8 yr 11 mo	U-2165
9808468	Mar 31, 2035	in 8 yr 11 mo	U-2160